FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients

NCT02935764 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

164

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Carcinoma

Interventions

DRUG: Irinotecan
DRUG: 5-fluorouracil
DRUG: Leucovorin

Sponsor

Fudan University